• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国东部地区角膜炎的人口统计学特征、相关危险因素及预后:一项基于共聚焦显微镜的十五年体内研究。

Demographic Characteristics, Contributing Risk Factors, and Prognosis of Keratitis in Eastern China: An in vivo Confocal Microscopy-Based Fifteen-Year Study.

作者信息

Lu Chuwei, Wang Jiajia, Hong Jiaxu, Xu Jianjiang, Zhou Xujiao, Tian Lijia, Le Qihua

机构信息

Department of Ophthalmology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, People's Republic of China.

NHC Key Laboratory of Myopia and Related Eye Diseases, Shanghai, People's Republic of China.

出版信息

Clin Ophthalmol. 2025 Sep 9;19:3295-3305. doi: 10.2147/OPTH.S545322. eCollection 2025.

DOI:10.2147/OPTH.S545322
PMID:40949823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12433226/
Abstract

PURPOSE

To investigate the demographic characteristics, contributing risk factors, and prognostic outcomes of keratitis (AK) in Eastern China in the recent 15 years using in vivo confocal microscopy (IVCM).

PATIENTS AND METHODS

This single-center, retrospective study included 145 patients (147 eyes) diagnosed with AK based on IVCM findings at the Eye & ENT Hospital of Fudan University from April 2009 to September 2024. Demographic information, clinical features at presentation, contributing risk factors (if identified), treatment strategies, and final visual outcomes were retrieved in the medical records and analyzed using descriptive statistics.

RESULTS

The median age of patients was 51 years old, with 98.6% of infections being unilateral. Corneal trauma (62.1%) was the leading risk factor overall, whereas contact lens wear was the independent risk factor among children and adolescents. The most common clinical features at presentation were stromal infiltrate (60.6%) and deep stromal ulcers (36.5%). Anti-AK therapy was mainly composed of polyhexamethylene biguanide (PHMB), chlorhexidine, propamidine isethionate (Brolene) and metronidazole. Surgical interventions were required in 24 eyes, with evisceration/enucleation identified as an independent predictor of poor visual prognosis.

CONCLUSION

This study provides valuable epidemiological insights into AK in Eastern China, underscoring the need for improved prevention, early diagnosis, and evidence-based treatment protocols to guide clinical management.

摘要

目的

利用活体共聚焦显微镜(IVCM)研究中国东部地区近15年角膜溃疡(AK)的人口统计学特征、相关危险因素及预后结果。

患者与方法

本单中心回顾性研究纳入了2009年4月至2024年9月在复旦大学附属眼耳鼻喉科医院根据IVCM检查结果诊断为AK的145例患者(147只眼)。从病历中获取人口统计学信息、就诊时的临床特征、相关危险因素(若已确定)、治疗策略及最终视力结果,并采用描述性统计方法进行分析。

结果

患者的中位年龄为51岁,98.6%的感染为单眼。角膜外伤(62.1%)是总体上的主要危险因素,而佩戴隐形眼镜是儿童和青少年中的独立危险因素。就诊时最常见的临床特征是基质浸润(60.6%)和深层基质溃疡(36.5%)。抗AK治疗主要由聚六亚甲基双胍(PHMB)、氯己定、依西酸丙脒(Brolene)和甲硝唑组成。24只眼需要手术干预,眼球内容剜除术/眼球摘除术被确定为视力预后不良的独立预测因素。

结论

本研究为中国东部地区的AK提供了有价值的流行病学见解,强调需要改进预防、早期诊断及循证治疗方案以指导临床管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf9/12433226/1fee28b2f552/OPTH-19-3295-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf9/12433226/41bd65200849/OPTH-19-3295-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf9/12433226/ab307b8ee36c/OPTH-19-3295-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf9/12433226/1fee28b2f552/OPTH-19-3295-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf9/12433226/41bd65200849/OPTH-19-3295-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf9/12433226/ab307b8ee36c/OPTH-19-3295-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf9/12433226/1fee28b2f552/OPTH-19-3295-g0003.jpg

相似文献

1
Demographic Characteristics, Contributing Risk Factors, and Prognosis of Keratitis in Eastern China: An in vivo Confocal Microscopy-Based Fifteen-Year Study.中国东部地区角膜炎的人口统计学特征、相关危险因素及预后:一项基于共聚焦显微镜的十五年体内研究。
Clin Ophthalmol. 2025 Sep 9;19:3295-3305. doi: 10.2147/OPTH.S545322. eCollection 2025.
2
Medical interventions for acanthamoeba keratitis.棘阿米巴角膜炎的医学干预措施。
Cochrane Database Syst Rev. 2015 Feb 24;2015(2):CD010792. doi: 10.1002/14651858.CD010792.pub2.
3
keratitis in a tertiary referral hospital in central China: demographics, risk factors, clinical presentation, treatments and outcomes.中国中部一家三级转诊医院的角膜炎:人口统计学、危险因素、临床表现、治疗及转归
Int J Ophthalmol. 2025 Jun 18;18(6):1016-1022. doi: 10.18240/ijo.2025.06.07. eCollection 2025.
4
Perspectives on the Incidence of Acanthamoeba Keratitis: A Systematic Review and Meta-Analysis.棘阿米巴角膜炎发病率的研究视角:一项系统评价与荟萃分析
Ophthalmology. 2025 Feb;132(2):206-218. doi: 10.1016/j.ophtha.2024.08.003. Epub 2024 Aug 9.
5
Nocardia Keratitis诺卡菌性角膜炎
6
Successful Treatment of Acanthamoeba Keratitis According to New Protocol with Polihexanide 0.08% Therapy: Case Report.根据含0.08%聚己双胍的新方案成功治疗棘阿米巴角膜炎:病例报告
Reports (MDPI). 2025 Apr 4;8(2):44. doi: 10.3390/reports8020044.
7
Treatment of keratitis with high dose PHMB (0.08%) monotherapy in clinical practice: A case series.临床实践中高剂量聚六亚甲基双胍(0.08%)单药治疗角膜炎:病例系列
Eur J Ophthalmol. 2024 Nov 14:11206721241299470. doi: 10.1177/11206721241299470.
8
The Natural History of Acanthamoeba Keratitis: A Systematic Literature Review.棘阿米巴角膜炎的自然史:一项系统文献综述
Ophthalmol Ther. 2025 May 5. doi: 10.1007/s40123-025-01152-9.
9
Clinical presentation, genotypic diversity, and intracellular bacteria in keratitis patients treated at a referral eye hospital in Sydney, Australia.澳大利亚悉尼一家转诊眼科医院治疗的角膜炎患者的临床表现、基因型多样性和细胞内细菌
IJID Reg. 2025 Jun 15;16:100690. doi: 10.1016/j.ijregi.2025.100690. eCollection 2025 Sep.
10
Topical antibiotics for treating bacterial keratitis: a network meta-analysis.用于治疗细菌性角膜炎的局部用抗生素:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jul 29;7(7):CD015350. doi: 10.1002/14651858.CD015350.pub2.

本文引用的文献

1
A novel artificial intelligence model for diagnosing Acanthamoeba keratitis through confocal microscopy.一种通过共聚焦显微镜诊断棘阿米巴角膜炎的新型人工智能模型。
Ocul Surf. 2024 Oct;34:159-164. doi: 10.1016/j.jtos.2024.07.010. Epub 2024 Jul 29.
2
Understanding Acanthamoeba Keratitis: An In-Depth Review of a Sight-Threatening Eye Infection.了解棘阿米巴角膜炎:对一种威胁视力的眼部感染的深入综述。
Microorganisms. 2024 Apr 9;12(4):758. doi: 10.3390/microorganisms12040758.
3
Acanthamoeba keratitis - A review.棘阿米巴角膜炎——综述。
Indian J Ophthalmol. 2024 Apr 1;72(4):473-482. doi: 10.4103/IJO.IJO_2627_23. Epub 2024 Mar 8.
4
Clinical outcomes and prognostic factors in Acanthamoeba keratitis.棘阿米巴角膜炎的临床结果和预后因素。
Cont Lens Anterior Eye. 2024 Apr;47(2):102119. doi: 10.1016/j.clae.2023.102119. Epub 2024 Jan 13.
5
Clinical Profile and Demographic Distribution of Keratitis: An Electronic Medical Record-Driven Data Analytics from an Eye Care Network in India.印度眼保健网络的电子病历驱动数据分析:角膜炎的临床特征和人口统计学分布。
Ocul Immunol Inflamm. 2024 Jul;32(5):722-726. doi: 10.1080/09273948.2023.2199331. Epub 2023 Apr 21.
6
The global epidemiology and clinical diagnosis of Acanthamoeba keratitis.棘阿米巴角膜炎的全球流行病学和临床诊断。
J Infect Public Health. 2023 Jun;16(6):841-852. doi: 10.1016/j.jiph.2023.03.020. Epub 2023 Mar 23.
7
Efficacy, predictability and safety of long-term orthokeratology: An 18-year follow-up study.长期角膜塑形术的疗效、可预测性和安全性:一项 18 年随访研究。
Cont Lens Anterior Eye. 2022 Feb;45(1):101530. doi: 10.1016/j.clae.2021.101530. Epub 2021 Nov 14.
8
Progression of myopia in a natural cohort of Chinese children during COVID-19 pandemic.新冠疫情期间中国自然人群儿童近视进展。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2813-2820. doi: 10.1007/s00417-021-05305-x. Epub 2021 Jul 21.
9
Challenges in Acanthamoeba Keratitis: A Review.棘阿米巴角膜炎的挑战:综述
J Clin Med. 2021 Mar 1;10(5):942. doi: 10.3390/jcm10050942.
10
The biology of Acanthamoeba keratitis.棘阿米巴角膜炎的生物学
Exp Eye Res. 2021 Jan;202:108365. doi: 10.1016/j.exer.2020.108365. Epub 2020 Nov 19.